Cardiac resynchronization therapy in patients with a history of atrial fibrillation: insights from five major clinical trials
Event: EHRA 2022
Topic: Device Treatment
Session: CRT news
Rate versus rhythm control and mortality in atrial fibrillation patients: a danish nationwide cohort study
Event: ESC Congress 2019
Topic: Treatment
Session: Blockbusters from the Young in atrial fibrillation and cardiac resynchronisation therapy
Increased risk of cardiovascular events and stroke among patients with atrial fibrillation and obstructive sleep apnea
Event: ESC Congress 2019
Topic: Epidemiology, Prognosis, Outcome
Session: Epidemiology of atrial fibrillation, miscellaneous
Rate lowering and anti-arrhythmic drugs as monotherapy or dual therapy on the risk of pacemaker implantation in patients with atrial fibrillation
Event: EHRA 2018
Topic: Antiarrhythmic Drug Treatment
Session: Young EP Poster Session - Young meets Experienced
Risk factors of permanent pacemaker implantation in patients with new onset atrial fibrillation
Event: ESC Congress 2017
Topic: Risk scores
Session: Adverse outcome in patients with cardiometabolic disorders
ESC 365 is supported by
